|
시장보고서
상품코드
1372496
신생아 스크리닝 시장 규모 및 예측, 세계 및 지역 점유율, 동향, 성장 기회 분석 리포트 대상 범위 : 제품 유형별, 기술별, 검사 유형별, 최종사용자별, 지역별Newborn Screening Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type, Technology, Test Type, End User, and Geography |
||||||
세계의 신생아 스크리닝 시장은 2022년 12억 600만 달러에서 2030년에는 24억 8,400만 달러에 달할 것으로 예측되고 있습니다. 이 시장은 2022-2030년 CAGR 9.4%로 성장할 것으로 추정됩니다.
시장을 촉진하는 주요 요인으로는 선천성 질환 부담 증가와 신생아 질환의 유병률 증가를 들 수 있습니다. 그러나 신생아 스크리닝 방침과 절차가 세계에서 통일되어 있지 않은 것 및 위양성·위음성 결과가 시장 성장 방해가 되고 있습니다.
신생아 스크리닝 시장의 시장 기회
병의 유전적 원인에 대한 지식이 깊어지고 의료 기술이 발전함에 따라 신생아에 대한 종합적인 유전자 검사에 대한 수요가 증가하고 있습니다. 이에 따라 신생아 검진 시장의 기업은 혁신적이고 비용 효율적인 검진 솔루션을 개발하고 있습니다. 미국 FDA는 2017년 특정 유형의 급성 림프모구 백혈병 소아 환자에게 사용하기 위해 킴리아(Kymriah) 유전자 치료제를 승인했습니다. 이 치료법은 키메라 항원 수용체를 코딩하는 새로운 유전자를 환자의 T세포에 삽입하여 변화된 T세포를 자극하여 백혈병 세포를 쫓아 파괴하는 방식입니다. 예스카르타와 진테그로는 대세포 B세포 림프종과 베타-サラセミア에 대해 승인된 유전자 치료의 두 가지 예입니다. 또한 출생시 질병의 유전적 소인을 파악할 수 있는 기술의 출현은 개인 맞춤형 의료의 길을 열어주며, 정밀의료의 광범위한 추세와도 일치합니다.
임신 중 유전성 질환의 선별 검사는 임신과 관련된 문제를 조기에 발견하는 데 초점을 맞추고 있습니다. 차세대 염기서열 분석기는 모든 염색체에서 다운증후군, 삼염색체 21과 같은 이수성 및 부분적인 염색체 이상(중복 및 결실)을 95% 이상의 민감도로 감지하여 신생아 산전 선별검사를 지원합니다. 형광 in-situ hybridization(FISH)은 겸상 적혈구 빈혈과 같은 단발성 질환을 검출하는 데 사용됩니다. 모체 혈장을 이용한 무세포 태아 DNA 접근법과 같은 비침습적 절차는 유전자 검사의 최근 발전입니다. 배아 DNA는 크기 차이로 인해 모체 DNA 조각과 구별할 수 있습니다. 형광 프로브를 이용한 실시간 PCR, 샷건 시퀀싱(Solexa 또는 Illumina) 또는 거대 표적 병렬 시퀀싱을 통해 태아의 질병과 관련된 DNA를 검사할 수 있습니다. 이러한 유형의 유전자 스크리닝이 더 많이 연구되면 의사는 특정 약리요법(약리유전학)을 통해 조기에 분자적 개입을 하거나 세포, 조직, 장기를 물리적으로 또는 화학적으로 변화시킬 수 있습니다. 이처럼 유아의 유전성 질환을 선별하는 방법의 발전은 신생아 선별검사 시장 전체에 엄청난 잠재력을 가지고 있습니다.
신생아 선별검사 시장을 저해하는 요인들
국가마다 검진하는 질병 리스트이 다르기 때문에 세계에서 신생아 검진 정책이나 시행 방법이 통일되어 있지 않습니다. 일부 국가는 종합적인 질병을 선별하는 반면, 일부 국가는 한정된 질병에 초점을 맞추고 있습니다. 이러한 차이는 선별 검사 및 기술을 개발하는 기업에게 장벽이 되고, 특정 시장에 맞게 제품을 변경해야 하기 때문에 규모의 경제를 제한합니다. 또한 표준화된 프로토콜이 없기 때문에 품질 관리와 데이터 수집에 일관성이 없습니다. 이로 인해 검진 결과의 부정확성과 지역 간 데이터 비교가 어려워져 연구자와 의료 서비스 프로바이더가 조사 대상 지역에서 시행되는 검진 프로그램의 효과를 평가하기 어렵습니다. 또한 보편적인 표준이 없기 때문에 신생아 선별검사 시장에서 사업을 운영하는 기업은 복잡한 규제 환경을 마주하게 됩니다. 각국의 승인을 받으려면 복잡한 규제망을 준수하는 데 집중해야 하기 때문에 시간과 비용이 많이 소요됩니다. 통일성 부족은 또한 국제적인 공동 연구와 데이터 공유를 방해하여 신생아 선별검사 연구와 기술 개발의 가능성을 제한합니다. 이처럼 신생아 선별검사 정책과 절차가 통일되지 않아 신생아 선별검사 시장의 발전을 제한하고 있습니다.
신생아 선별 검사 시장 부문별 개요
신생아 선별검사 시장은 제품 유형별로 시약 및 분석 키트와 기기로 구분되며, 2022년에는 시약 및 분석 키트 부문이 더 큰 시장 점유율을 차지하고 향후 수년간 가장 빠른 속도로 성장할 것으로 예상됩니다. 신생아 스크리닝을 위한 다양한 시약 및 분석 키트는 DNA 기반 분석, 면역 분석, 효소 분석으로 분류됩니다. 신흥 국가 시장에서는 다양한 기업이 신생아 선별검사 전용 시약 및 분석 키트를 개발하고 있습니다. 먼저, Labsystems Diagnostics는 신생아의 페닐알라닌 수치가 상승하면 지적 장애를 유발할 수 있으므로 페닐알라닌 함량을 기반으로 신생아 페닐케톤뇨증(PKU)을 검출하는 형광 마이크로플레이트 기반 분석법을 출시했습니다. 출시하였습니다. 당사가 제공하는 모든 시약 키트는 수동 모듈식 시스템 또는 완전 자동 핸즈 오프 시스템입니다.
신생아 스크리닝 시장은 기술별로 탠덤 질량 분석(TMS), 분자 분석, 면역 분석, 효소 분석, 맥박 산소 측정 스크리닝 기술 및 기타 기술로 분류되며, 2022년에는 맥박 산소 측정 스크리닝 기술 분야가 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.를 차지했습니다. 또한 면역 분석 및 효소 분석 분야는 향후 수년간 가장 빠르게 성장할 것으로 예상됩니다. 선천성 심장병(CCHD)은 가장 흔한 선천성 장애 중 하나이며, 관 의존성 선천성 심장 질환입니다. 출생 전이나 출생 후 발견되기도 하지만, 신생아기나 유아기에 진단 및 치료를 받지 못하면 생명을 위협할 수 있습니다. 맥박산소측정 검사로 영아에서 심각한 CCHD를 발견할 수 있습니다. 통증도 없고, 비침습적이며, 비용 효율적인 영아 선별검사 방법입니다. 펄스옥시미터 검사는 혈액내 헤모글로빈이 산소로 포화되어 있는 비율을 측정합니다.
신생아 선별검사 시장은 검사 유형에 따라 건식 혈액 반점 검사, 청력 검사, 중증 선천성 심장병 검사, 기타 검사로 구분되며, 2022년에는 혈액 반점 검사 부문이 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다. 이 부문의 신생아 선별검사 시장은 2022-2030년 상당한 CAGR로 성장할 것으로 추정됩니다.
신생아 검진 시장은 최종사용자별로 병원, 클리닉, 진단 실험실로 구분되며, 2022년에는 병원 및 클리닉 부문이 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 그러나 병원 및 클리닉 부문은 2022-2030년동안 CAGR로 성장할 것으로 예상됩니다. 의료 서비스 프로바이더는 병실 또는 신생아 및 수유실에서 신생아 선별 검사를 수행합니다. 병원 및 클리닉 부문은 향후 수년간 신생아 선별 검사를 위해 최대 환자 수를 수용하기 때문에 신생아 선별 검사 시장에서 더 큰 점유율을 차지할 것으로 예상됩니다. 더 나은 시설, 다양한 치료 옵션의 가용성, 한 지붕 아래에서 우수한 간호 서비스는 다양한 진단 및 치료 절차를 위해 환자를 이러한 시설로 끌어들입니다.
신생아 선별검사 시장 지역적 개요
북미 신생아 검진 시장은 최근 수년간 괄목할 만한 성장을 보이고 있습니다. 선천성 장애를 식별하고 관리하기 위한 조기 검진의 중요성에 대한 부모와 의료 전문가들의 인식이 높아지면서 신생아 검진 서비스에 대한 수요가 크게 증가하고 있습니다. 또한 의료 기술의 발전은 신생아 검진 능력을 향상시키는 데 매우 중요하며, 검사실 자동화는 검진의 정확성, 속도 및 비용 효율성을 향상시키고 있습니다. 이를 통해 의료 전문가들은 보다 광범위한 유전 및 대사 질환을 포괄하는 철저한 신생아 선별검사 패널을 제공할 수 있게 되었습니다. 유리한 법률 및 규제 조치도 북미 신생아 선별검사 시장에 도움이 되고 있습니다. 많은 주와 주에서 신생아 검진 의무화 프로그램을 시행하고 있으며, 모든 영아들이 출생 직후에 검진을 받을 수 있도록 하고 있습니다. 예를 들어 미국에서는 각 주에서 공중보건 프로그램으로 신생아 선별검사를 시행하고 있으며, 연간 약 400만 명의 영아들이 이 프로그램에 따라 출생시 잘 나타나지 않는 질병에 대한 선별검사를 받고 있습니다. 텍사스 주 보건 복지부는 2021년 6월부터 척수성 근위축증(SMA)에 대한 신생아 검진을 시작했습니다.
신생아 선별검사 시장 보고서를 작성할 때 참고한 주요 1차 및 2차 정보는 세계은행(World Bank) 데이터, 국가보건서비스(NHS), 미국 식품의약국(FDA), 유럽의약품청(EMA), 세계보건기구(WHO) 등입니다.
목차
제1장 서론
제2장 주요 요약
- 주요 인사이트
제3장 조사 방법
- 조사 범위
- 2차 조사
- 1차 조사
제4장 신생아 스크리닝 시장 상황
- PEST 분석
- 세계의 PEST 분석
제5장 신생아 스크리닝 시장 - 주요 산업 역학
- 시장 촉진요인
- 신생아 스크리닝에 대한 정부 자금의 급증
- 선천성 질환의 부담 증가
- 신생아 질환의 유병률 증가
- 주요 시장 억제요인
- 신생아 스크리닝 정책과 시행에서 통일성의 결여
- 주요 시장 기회
- 신생아 유전자 스크리닝
- 향후 동향
- 스크리닝에서 기계학습과 인공지능의 통합
- 영향 분석
제6장 신생아 스크리닝 시장 : 세계 시장 분석
- 신생아 스크리닝 시장 매출, 2022-2030년
제7장 세계의 신생아 스크리닝 시장 : 매출과 2030년까지의 예측 : 제품 유형별
- 신생아 스크리닝 시장의 제품 유형별 매출 점유율(2022년·2030년)
- 시약 및 어세이 키트
- 기기
제8장 세계의 신생아 스크리닝 시장 : 매출과 2030년까지의 예측 : 기술별
- 신생아 스크리닝 시장 매출 점유율, 기술별, 2022년 및 2030년(%)
- 텐덤 질량분석(TMS)
- 분자 어세이
- 면역 어세이 및 효소 어세이
- 펄스 옥시메트리 스크리닝 기술
- 기타 기술
제9장 세계의 신생아 스크리닝 시장 : 2030년까지의 매출과 예측 : 검사 유형별
- 신생아 스크리닝 시장 2022년 및 2030년에 매출 점유율(검사 유형별)
- Dry Blood Spot Test
- 청각 스크리닝 검사
- 중증 선천성 심질환(CCHD) 검사
- 기타 검사 유형
제10장 세계의 신생아 스크리닝 시장 : 최종사용자별 매출과 2030년까지의 예측
- 신생아 스크리닝 시장 최종사용자별 매출 점유율(2022년·2030년)
- 병원 및 진료소
- 진단 연구소
제11장 신생아 스크리닝 시장 : 지역별 분석
- 북미
- 멕시코
- 유럽
- 기타 유럽
- 아시아태평양
- 기타 아시아태평양
- 중동 및 아프리카
- 기타 중동 및 아프리카
- 중남미
- 기타 중남미
제12장 신생아 스크리닝 시장 - 업계 상황
- 신생아 스크리닝 시장에서의 성장 전략
- 유기적 성장 전략
- 무기적 성장 전략
제13장 기업 개요
- LifeCell International Pvt Ltd
- Zentech SA
- Trivitron Healthcare Pvt Ltd
- PerkinElmer Inc
- Waters Corp
- Bio-Rad Laboratories Inc
- Masimo Corp
- Natus Medical Inc.
- Baebies Inc
- MRC Holland BV
- Medtronic Plc
제14장 부록
KSA 23.11.08The global newborn screening market is expected to reach US$ 2.484 billion in 2030 from US$ 1.206 billion in 2022. The market is estimated to grow with a CAGR of 9.4% from 2022 to 2030.
The key factors driving the market include rising burden of congenital diseases and increasing prevalence of newborn disorders. However, lack of uniformity of newborn screening policies and procedures across the world and false positive and false negative results hinders the market growth.
Market Opportunities of Newborn Screening Market
The demand for comprehensive genetic screening of newborns is rising with the deepening knowledge about the genetic causes of medical conditions and advancements in healthcare technologies. As a result, companies in the newborn screening market are developing innovative, cost-effective screening solutions. The US FDA licensed the Kymriah gene therapy in 2017 for use in pediatric patients with a particular kind of acute lymphoblastic leukemia. During this therapy, a new gene that codes for a chimeric antigen receptor is inserted into the patient's T cells, stimulating the altered T cells to go after and destroy the leukemic cells. Yescarta and Zynteglo are two more examples of authorized gene treatments for large B-cell lymphoma and beta-thalassemia. Further, the emergence of technologies conferring an ability to identify genetic predispositions to diseases at birth pave the way for personalized healthcare, aligning with the broader trend of precision medicine.
Screening for genetic diseases during pregnancy also focuses on the early detection of pregnancy-related problems. Next-generation sequencing aids in the prenatal screening of neonates with a sensitivity of above 95% for detecting aneuploidies (such as Down syndrome and Trisomy 21) or partial chromosomal abnormalities (duplications or deletions) in all chromosomes. Fluorescence in-situ hybridization (FISH) is employed to detect monogenic illnesses such as sickle cell anemia; it also aids in an effective preimplantation genetic diagnosis. Noninvasive procedures such as the cell-free fetal DNA approach using maternal plasma are the recent advancements in genetic tests. The embryonic DNA can be distinguished from maternal DNA pieces based on differences in their sizes. Real-time PCR with fluorescent probes, shotgun sequencing (Solexa or Illumina), or huge targeted parallel sequencing can be used to examine DNA associated with fetal medical conditions. This would allow doctors to provide early molecular interventions with certain pharmacological therapies (pharmacogenetics) and to transform cells, tissues, and organs physically and chemically if this type of genetic screening is further researched. Thus, advancements in methods for screening infants for genetic disorders hold immense potential for the overall newborn screening market.
Factors Hampering Newborn Screening Market
Variations regarding the list of conditions screened for in different countries result in non-uniformity in newborn screening policies and practices worldwide. A few nations screen for a comprehensive range of disorders, while others focus on a limited set. This difference creates barriers for companies developing screening tests and technologies, as they need to modify their products to specific markets, limiting economies of scale. Moreover, the lack of standardized protocols can result in inconsistent quality control and data collection practices. This leads to inaccuracies in screening results and difficulties in comparing data between regions, making it challenging for researchers and healthcare providers to assess the effectiveness of screening programs implemented in localities understudy. Additionally, the absence of universal standards complicates the regulatory landscape for companies operating in the newborn screening market, as they need to focus on complying with a complex web of regulations for seeking approvals in different countries, which can be time-consuming and expensive. The lack of uniformity can also hinder international collaborations and data sharing, limiting the potential of newborn screening research and technology development. Thus, the lack of uniformity in newborn screening policies and procedures limits the progress of the newborn screening market.
Newborn Screening Market: Segmental Overview
The newborn screening market, by product type, is segmented into reagents and assay kits and instruments. In 2022, the reagents and assay kits segment held a larger market share and is expected to grow at the fastest rate in the coming years. Different reagents and assay kits for newborn screening are categorized into DNA-based assays, immunoassays, and enzymatic assays. Various companies in the market have developed a range of reagents and assay kits specifically for neonatal screening. Firstly, Labsystems Diagnostics launched a fluorometric microplate-based assay for detecting phenylketonuria (PKU) in newborns based on phenylalanine content, as increasing the phenylalanine level in the baby can cause intellectual disability. All the reagent kits offered by the Company are manual modular systems or fully automated hands-off systems.
The newborn screening market, by technology, is segmented into tandem mass spectrometry (TMS), molecular assays, immunoassays and enzymatic assays, pulse oximetry screening technology, and other technologies. In 2022, the pulse oximetry screening technology segment held the largest share of the market. Moreover, the immunoassays and enzymatic assays segment is expected to grow fastest during the coming years. Congenital heart disease (CCHD), one of the most common congenital disabilities, is a duct-dependent congenital heart disease. It may be detected during the prenatal and postnatal period, while it can be life-threatening if it goes undiagnosed and untreated in the neonatal period or infancy. Pulse oximetry screening is used to detect critical CCHD in infants. It is a painless, noninvasive, and cost-effective method of screening infants. The pulse oximeter screening determines the percentage of hemoglobin in the blood saturated with oxygen.
The newborn screening market, by test type, is segmented into dry blood spot tests, hearing screen tests, critical congenital heart disease tests, and other tests. In 2022, the blood spot test segment held the largest share of the market. The newborn screening market for the same segment is estimated to grow at a significant CAGR during 2022 -2030.
The newborn screening market, by end-user, is segmented into hospitals, clinics, and diagnostic laboratories. In 2022, the hospitals and clinics segment held a larger market share. However, the hospitals and clinics segment is estimated to grow at a CAGR during 2022-2030. healthcare provider performs newborn screening tests in a room or a newborn/nursery area at hospitals. The hospitals and clinics segment is projected to hold a larger share of the newborn screening market in the coming years as these facilities receive maximum patient footfall for newborn baby screening. Better facilities, and the availability of different treatment options and good nursing care under one roof attract patients toward these facilities for different diagnostic and therapeutic procedure.
Newborn Screening Market: Geographical Overview
The newborn screening market in North America has experienced significant growth in recent years. The demand for newborn screening services has increased significantly with the surging awareness among parents and healthcare professionals about the importance of early screening for identifying and managing congenital disorders. Additionally, improvements in medical technology have been crucial in enhancing newborn screening capabilities-laboratory automation has boosted screening accuracy, speed, and cost-effectiveness. This has made it possible for medical professionals to give thorough newborn screening panels that cover a larger spectrum of genetic and metabolic disorders. Favorable legislation and regulatory measures also benefit the newborn screening market in North America. Many states and provinces have implemented mandatory newborn screening programs, ensuring all infants are screened shortly after birth. For instance, every state in the US offers newborn screening as a public health program; yearly, ~4 million babies are screened under this program for illnesses that aren't often present at the time of delivery. The Texas Department of Health and Human Services began screening newborns for Spinal Muscular Atrophy (SMA) in June 2021.
A few of the major primary and secondary sources referred to while preparing the report on the newborn screening market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (World Health Organization).
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the newborn screening market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global newborn screening market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the newborn screening market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
- 2.1 Key Insights
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Newborn Screening Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.2.1 Global PEST Analysis
5. Newborn Screening Market - Key Industry Dynamics
- 5.1 Key Market Drivers
- 5.1.1 Surging Government Funding for Newborn Screening
- 5.1.2 Rising Burden of Congenital Diseases
- 5.1.3 Increasing Prevalence of Newborn Disorders
- 5.2 Key Market Restraints
- 5.2.1 Lack of Uniformity in Newborn Screening Policies and Practices
- 5.3 Key Market Opportunities
- 5.3.1 Genetic Screening of Newborns
- 5.4 Future Trends
- 5.4.1 Integration of Machine Learning and Artificial Intelligence in Screening
- 5.5 Impact Analysis:
6. Newborn Screening Market - Global Market Analysis
- 6.1 Newborn Screening Market Revenue (US$ Mn), 2022 - 2030
7. Global Newborn Screening Market - Revenue and Forecast to 2030 - by Product Type
- 7.1 Overview
- 7.2 Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
- 7.3 Reagents and Assay Kits
- 7.3.1 Overview
- 7.3.2 Reagents and Assay Kits: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.2.1 Global Newborn Screening Market, by Reagents and Assay Kits, 2020-2030 (US$ Million)
- 7.4 Instruments
- 7.4.1 Overview
- 7.4.2 Instruments: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.2.1 Global Newborn Screening Market, by Instruments, 2020-2030 (US$ Million)
8. Global Newborn Screening Market - Revenue and Forecast to 2030 - by Technology
- 8.1 Overview
- 8.2 Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
- 8.3 Tandem Mass Spectrometry (TMS)
- 8.3.1 Overview
- 8.3.2 Tandem Mass Spectrometry (TMS): Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
- 8.4 Molecular Assays
- 8.4.1 Overview
- 8.4.2 Molecular Assays: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
- 8.5 Immunoassays and Enzymatic Assays
- 8.5.1 Overview
- 8.5.2 Immunoassays and Enzymatic Assays: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
- 8.6 Pulse Oximetry Screening Technology
- 8.6.1 Overview
- 8.6.2 Pulse Oximetry Screening Technology: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
- 8.7 Other Technologies
- 8.7.1 Overview
- 8.7.2 Other Technologies: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
9. Global Newborn Screening Market - Revenue and Forecast to 2030 - by Test Type
- 9.1 Overview
- 9.2 Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
- 9.3 Dry Blood Spot Test
- 9.3.1 Overview
- 9.3.2 Dry Blood Spot Test: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
- 9.4 Hearing Screen Test
- 9.4.1 Overview
- 9.4.2 Hearing Screen Test: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
- 9.5 Critical Congenital Heart Diseases (CCHD) Test
- 9.5.1 Overview
- 9.5.2 Critical Congenital Heart Diseases (CCHD) Test: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
- 9.6 Other Test Types
- 9.6.1 Overview
- 9.6.2 Other Test Types: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
10. Global Newborn Screening Market - Revenue and Forecast to 2030 - by End User
- 10.1 Overview
- 10.2 Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
- 10.3 Hospitals and Clinics
- 10.3.1 Overview
- 10.3.2 Hospitals and Clinics: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
- 10.4 Diagnostic Laboratories
- 10.4.1 Overview
- 10.4.2 Diagnostic Laboratories: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
11. Newborn Screening Market - Geographical Analysis
- 11.1 North America Newborn Screening Market, Revenue and Forecast To 2030
- 11.1.1 Overview
- 11.1.2 North America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.3 North America: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
- 11.1.3.1 North America: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
- 11.1.3.2 North America: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.1.4 North America: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.1.5 North America: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.1.6 North America: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
- 11.1.6.1 North America Newborn Screening Market, by Country
- 11.1.6.2 US
- 11.1.6.2.1 US Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.6.2.2 US: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
- 11.1.6.2.2.1 US: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
- 11.1.6.2.2.2 US: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.1.6.2.3 US: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.1.6.2.4 US: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.1.6.2.5 US: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
- 11.1.6.3 Canada
- 11.1.6.3.1 Canada Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.6.3.2 Canada: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
- 11.1.6.3.2.1 Canada: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
- 11.1.6.3.2.2 Canada: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.1.6.3.3 Canada: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.1.6.3.4 Canada: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.1.6.3.5 Canada: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
- 11.1.6.4 Mexico
- 11.1.6.4.1 Mexico Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.6.4.2 Mexico: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
- 11.1.6.4.2.1 Mexico: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
- 11.1.6.4.2.2 Mexico: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.1.6.4.3 Mexico: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.1.6.4.4 Mexico: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.1.6.4.5 Mexico: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
- 11.2 Europe Newborn Screening Market, Revenue and Forecast to 2030
- 11.2.1 Overview
- 11.2.2 Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.2.3 Europe: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
- 11.2.3.1 Europe: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
- 11.2.3.2 Europe: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.2.4 Europe: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.2.5 Europe: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.2.6 Europe: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
- 11.2.6.1 Europe Newborn Screening Market, by Country
- 11.2.6.2 UK
- 11.2.6.2.1 UK Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.2.6.2.2 UK: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
- 11.2.6.2.2.1 UK: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
- 11.2.6.2.2.2 UK: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.2.6.2.3 UK: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.2.6.2.4 UK: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.2.6.2.5 UK: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
- 11.2.6.3 Germany
- 11.2.6.3.1 Germany Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.2.6.3.2 Germany: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
- 11.2.6.3.2.1 Germany: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
- 11.2.6.3.2.2 Germany: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.2.6.3.3 Germany: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.2.6.3.4 Germany: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.2.6.3.5 Germany: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
- 11.2.6.4 France
- 11.2.6.4.1 France Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.2.6.4.2 France: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
- 11.2.6.4.2.1 France: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
- 11.2.6.4.2.2 France: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.2.6.4.3 France: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.2.6.4.4 France: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.2.6.4.5 France: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
- 11.2.6.5 Italy
- 11.2.6.5.1 Italy Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.2.6.5.2 Italy: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
- 11.2.6.5.2.1 Italy: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
- 11.2.6.5.2.2 Italy: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.2.6.5.3 Italy: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.2.6.5.4 Italy: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.2.6.5.5 Italy: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
- 11.2.6.6 Spain
- 11.2.6.6.1 Spain Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.2.6.6.2 Spain: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
- 11.2.6.6.2.1 Spain: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
- 11.2.6.6.2.2 Spain: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.2.6.6.3 Spain: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.2.6.6.4 Spain: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.2.6.6.5 Spain: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
- 11.2.6.7 Rest of Europe
- 11.2.6.7.1 Rest of Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.2.6.7.2 Rest of Europe: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
- 11.2.6.7.2.1 Rest of Europe: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
- 11.2.6.7.2.2 Rest of Europe: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.2.6.7.3 Rest of Europe: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.2.6.7.4 Rest of Europe: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.2.6.7.5 Rest of Europe: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
- 11.3 Asia Pacific Newborn Screening Market, Revenue and Forecast to 2030
- 11.3.1 Overview
- 11.3.2 Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.3.3 Asia Pacific: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
- 11.3.3.1 Asia Pacific: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
- 11.3.3.2 Asia Pacific: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.3.4 Asia Pacific: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.3.5 Asia Pacific: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.3.6 Asia Pacific: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
- 11.3.6.1 Asia Pacific Newborn Screening Market, by Country
- 11.3.6.2 China
- 11.3.6.2.1 China Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.3.6.2.2 China: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
- 11.3.6.2.2.1 China: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
- 11.3.6.2.2.2 China: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.3.6.2.3 China: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.3.6.2.4 China: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.3.6.2.5 China: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
- 11.3.6.3 Japan
- 11.3.6.3.1 Japan Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.3.6.3.2 Japan: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
- 11.3.6.3.2.1 Japan: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
- 11.3.6.3.2.2 Japan: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.3.6.3.3 Japan: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.3.6.3.4 Japan: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.3.6.3.5 Japan: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
- 11.3.6.4 India
- 11.3.6.4.1 India Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.3.6.4.2 India: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
- 11.3.6.4.2.1 India: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
- 11.3.6.4.2.2 India: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.3.6.4.3 India: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.3.6.4.4 India: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.3.6.4.5 India: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
- 11.3.6.5 Australia
- 11.3.6.5.1 Australia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.3.6.5.2 Australia: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
- 11.3.6.5.2.1 Australia: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
- 11.3.6.5.2.2 Australia: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.3.6.5.3 Australia: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.3.6.5.4 Australia: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.3.6.5.5 Australia: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
- 11.3.6.6 South Korea
- 11.3.6.6.1 South Korea Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.3.6.6.2 South Korea: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
- 11.3.6.6.2.1 South Korea: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
- 11.3.6.6.2.2 South Korea: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.3.6.6.3 South Korea: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.3.6.6.4 South Korea: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.3.6.6.5 South Korea: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
- 11.3.6.7 Rest of Asia Pacific
- 11.3.6.7.1 Rest of Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.3.6.7.2 Rest of Asia Pacific: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
- 11.3.6.7.2.1 Rest of Asia Pacific: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
- 11.3.6.7.2.2 Rest of Asia Pacific: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.3.6.7.3 Rest of Asia Pacific: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.3.6.7.4 Rest of Asia Pacific: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.3.6.7.5 Rest of Asia Pacific: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
- 11.4 Middle East & Africa Newborn Screening Market, Revenue and Forecast to 2030
- 11.4.1 Overview
- 11.4.2 Middle East & Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.4.3 Middle East & Africa: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
- 11.4.3.1 Middle East & Africa: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
- 11.4.3.2 Middle East & Africa: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.4.4 Middle East & Africa: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.4.5 Middle East & Africa: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.4.6 Middle East & Africa: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
- 11.4.6.1 Middle East & Africa Newborn Screening Market, by Country
- 11.4.6.2 Saudi Arabia
- 11.4.6.2.1 Saudi Arabia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.4.6.2.2 Saudi Arabia: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
- 11.4.6.2.2.1 Saudi Arabia: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
- 11.4.6.2.2.2 Saudi Arabia: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.4.6.2.3 Saudi Arabia: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.4.6.2.4 Saudi Arabia: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.4.6.2.5 Saudi Arabia: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
- 11.4.6.3 UAE
- 11.4.6.3.1 UAE Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.4.6.3.2 UAE: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
- 11.4.6.3.2.1 UAE: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
- 11.4.6.3.2.2 UAE: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.4.6.3.3 UAE: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.4.6.3.4 UAE: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.4.6.3.5 UAE: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
- 11.4.6.4 South Africa
- 11.4.6.4.1 South Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.4.6.4.2 South Africa: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
- 11.4.6.4.2.1 South Africa: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
- 11.4.6.4.2.2 South Africa: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.4.6.4.3 South Africa: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.4.6.4.4 South Africa: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.4.6.4.5 South Africa: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
- 11.4.6.5 Rest of Middle East & Africa
- 11.4.6.5.1 Rest of Middle East & Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.4.6.5.2 Rest of Middle East & Africa: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
- 11.4.6.5.2.1 Rest of Middle East & Africa: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
- 11.4.6.5.2.2 Rest of Middle East & Africa: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.4.6.5.3 Rest of Middle East & Africa: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.4.6.5.4 Rest of Middle East & Africa: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.4.6.5.5 Rest of Middle East & Africa: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
- 11.5 South & Central America Newborn Screening Market, Revenue and Forecast to 2030
- 11.5.1 Overview
- 11.5.2 South & Central America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.5.3 South & Central America: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
- 11.5.3.1 South & Central America: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
- 11.5.3.2 South & Central America: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.5.4 South & Central America: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.5.5 South & Central America: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.5.6 South & Central America: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
- 11.5.6.1 South & Central America Newborn Screening Market, by Country
- 11.5.6.2 Brazil
- 11.5.6.2.1 Brazil Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.5.6.2.2 Brazil: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
- 11.5.6.2.2.1 Brazil: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
- 11.5.6.2.2.2 Brazil: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.5.6.2.3 Brazil: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.5.6.2.4 Brazil: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.5.6.2.5 Brazil: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
- 11.5.6.3 Argentina
- 11.5.6.3.1 Argentina Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.5.6.3.2 Argentina: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
- 11.5.6.3.2.1 Argentina: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
- 11.5.6.3.2.2 Argentina: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.5.6.3.3 Argentina: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.5.6.3.4 Argentina: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.5.6.3.5 Argentina: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
- 11.5.6.4 Rest of South & Central America
- 11.5.6.4.1 Rest of South & Central America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.5.6.4.2 Rest of South & Central America: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
- 11.5.6.4.2.1 Rest of South & Central America: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
- 11.5.6.4.2.2 Rest of South & Central America: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.5.6.4.3 Rest of South & Central America: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.5.6.4.4 Rest of South & Central America: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.5.6.4.5 Rest of South & Central America: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
12. Newborn Screening Market-Industry Landscape
- 12.1 Overview
- 12.2 Growth Strategies in Newborn Screening Market
- 12.3 Organic Growth Strategies
- 12.3.1 Overview
- 12.4 Inorganic Growth Strategies
- 12.4.1 Overview
13. Company Profiles
- 13.1 LifeCell International Pvt Ltd
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
- 13.2 Zentech SA
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
- 13.3 Trivitron Healthcare Pvt Ltd
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
- 13.4 PerkinElmer Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
- 13.5 Waters Corp
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
- 13.6 Bio-Rad Laboratories Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
- 13.7 Masimo Corp
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
- 13.8 Natus Medical Inc.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
- 13.9 Baebies Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
- 13.10 MRC Holland BV
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
- 13.11 Medtronic Plc
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
14. Appendix
- 14.1 About Us
- 14.2 Glossary of Terms
